Literature DB >> 3312062

Hormonal changes in haemodialysed and in kidney-transplanted patients.

L Lócsey1, A Lenkey, A Leövey.   

Abstract

A total of 48 haemodialysed patients were studied by radioimmunoassay for the serum concentrations of parathormone, calcitonin, gastrin, insulin, prolactin, T3, T4, rT3, TSH and cortisol. Residual urines were measured for cAMP and ultrafiltrates for iPTH and gastrin. The duration of the dialysis programme, the number of haemodialysis sessions per week, sex distribution, the dialysis alternatives (including haemofiltration, haemoperfusion) and successful kidney transplantations were correlated with the serum hormone levels. Significant increases in PTH, gastrin and prolactin values were demonstrated in the dialysed patients. However, their calcitonin and insulin concentrations decreased, parallel with the time elapsed since the start of the haemodialysis programme (HDP). The number of dialysis sessions per week was found to affect the hormone concentrations diversely. In the course of haemofiltration and haemoperfusion some of the hormone levels (e.g. PTH, gastrin) decreased significantly. The patients were in general euthyroid. One of them, on HDP for several years, developed clinical and laboratory signs indicative of hyperthyroidism. In a considerable proportion of the cases the results of the hormone studies (increased PTH, CT, cAMP) were consistent with secondary hyperparathyroidism. Kidney transplantation was followed by a decline of the serum prolactin, parathormone, calcitonin and aldosterone levels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312062     DOI: 10.1007/BF02550474

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  20 in total

1.  Letter: Human calcitonin, serum-phosphate, renal failure.

Authors:  J Szücs
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

2.  [Hormonal changes in and therapy of renal osteodystrophy].

Authors:  L Löcsey; G Kakuk; T Szabó; I Wórum; Z Nagy; A Leövey
Journal:  Orv Hetil       Date:  1980-08-31       Impact factor: 0.540

3.  Does cimetidine inhibit parathyroid hormone secretion?

Authors:  J Sherwood; D Reinhard; M Garcia
Journal:  N Engl J Med       Date:  1979-01-25       Impact factor: 91.245

4.  [Serum prolactin, testosterone, dehydroepiandrosterone and dehydroepiandrosterone sulphate levels in chronic uremic patients treated by hemodialysis].

Authors:  J Szücs; J Makó; T Fehér; T Györgyi; M Szathmári
Journal:  Orv Hetil       Date:  1984-07-29       Impact factor: 0.540

5.  Serum reverse triiodothyronine (3,3',5'-L-triiodothyronine) in end-stage renal failure.

Authors:  M Weissel; H K Stummvoll
Journal:  Nephron       Date:  1981       Impact factor: 2.847

6.  Cyclical changes in serum thyroid hormone concentrations related to hemodialysis: movement of hormone into and out of the extravascular space as a possible mechanism.

Authors:  R van Leusen; A E Meinders
Journal:  Clin Nephrol       Date:  1982-10       Impact factor: 0.975

7.  Effect of cimetidine on basal and histamine-induced secretion of parathyroid hormone in vitro.

Authors:  P K Wagner; U Krause; T Schärfe; J Beyer; M Rothmund
Journal:  Nephron       Date:  1984       Impact factor: 2.847

8.  Thyroid status in patients with chronic renal failure.

Authors:  G J Beckett; C J Henderson; R Elwes; J Seth; A T Lambie
Journal:  Clin Nephrol       Date:  1983-04       Impact factor: 0.975

9.  Serum thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis and regular hemodialysis.

Authors:  B Thysen; M Gatz; R Freeman; B E Alpert; C Charytan
Journal:  Nephron       Date:  1983       Impact factor: 2.847

10.  Thyroid function in patients undergoing maintenance hemodialysis: unexplained low serum thyroxine concentration.

Authors:  J M Hershman; L G Krugman; J D Kopple; A W Reed; M Azukizawa; J H Shinaberger
Journal:  Metabolism       Date:  1978-07       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.